Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL01Antineoplastic agents
- Pharmacological subgroupL01E
- Chemical subgroupL01EL
- Chemical substanceL01EL01Ibrutinib
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 6 registrations
- Imbruvica70 MG / ML · Suspension · Janssen INC
- Imbruvica140 MG · Capsule · Janssen INC
- Imbruvica140 MG · Tablet · Janssen INC
- Imbruvica420 MG · Tablet · Janssen INC
Spain
AEMPS · 6 registrations
At a glance
- ATC code
- L01EL01
- Registers
- 11
- Historical lists
- 3
- Registrations
- 45
- With their own page
- 32
- Companies
- 15
All medicines with Ibrutinib
Human medicines from every register that match Ibrutinib by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
45 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Imbruvica | United States | 70MG/ML | suspension | Marketed | Pharmacyclics LLC |
| Imbruvica | United States | 140MG, 230MG, 280MG … | tablet | Marketed | Pharmacyclics LLC |
| Imbruvica | United States | 140MG, 70MG | capsule | Marketed | Pharmacyclics LLC |
| Imbruvica | European Union | Authorised | Janssen-Cilag International NV | ||
| Imbruvica 140 MG Capsulas Duras | Spain | 140 mg | cápsula dura | Marketed | Janssen-Cilag International N.V |
| Imbruvica 140 MG Comprimidos Recubiertos con Pelicula | Spain | 140 mg | comprimido recubierto con película | Marketed | Janssen-Cilag International N.V |
| Imbruvica 280 MG Comprimidos Recubiertos con Pelicula | Spain | 280 mg | comprimido recubierto con película | Marketed | Janssen-Cilag International N.V |
| Imbruvica 420 MG Comprimidos Recubiertos con Pelicula | Spain | 420 mg | comprimido recubierto con película | Marketed | Janssen-Cilag International N.V |
| Imbruvica 560 MG Comprimidos Recubiertos con Pelicula | Spain | 560 mg | comprimido recubierto con película | Marketed | Janssen-Cilag International N.V |
| Imbruvica | Canada | 140 MG | Capsule | Marketed | Janssen INC |
| Imbruvica | Canada | 70 MG / ML | Suspension | Marketed | Janssen INC |
| Imbruvica 140 MG Capsulas Duras | Spain | 140 mg | cápsula dura | Authorised | Janssen-Cilag International N.V |
| IMBRUVICA 140 mg, harde capsules | Netherlands | Capsule, hard | Authorised | Janssen-Cilag International NV | |
| IMBRUVICA 140 mg filmomhulde tabletten | Netherlands | Filmomhulde tablet | Authorised | Janssen-Cilag International NV | |
| IMBRUVICA 280 mg filmomhulde tabletten | Netherlands | Filmomhulde tablet | Authorised | Janssen-Cilag International NV | |
| IMBRUVICA 420 mg filmomhulde tabletten | Netherlands | Filmomhulde tablet | Authorised | Janssen-Cilag International NV | |
| IMBRUVICA 560 mg filmomhulde tabletten | Netherlands | Filmomhulde tablet | Authorised | Janssen-Cilag International NV | |
| Imbruvica | Brazil | Authorised | Janssen-Cilag Farmacêutica Ltda | ||
| Imbruvica | Canada | 140 MG | Tablet | Authorised | Janssen INC |
| Imbruvica | Canada | 280 MG | Tablet | Authorised | Janssen INC |
| Imbruvica | Brazil | Authorised | Janssen-Cilag Farmacêutica Ltda | ||
| Imbruvica | Canada | 420 MG | Tablet | Authorised | Janssen INC |
| Imbruvica | Canada | 560 MG | Tablet | Authorised | Janssen INC |
| Imbruvica® | Serbia | 140mg | kapsula, tvrda | Authorised | PredstavniŠTvo Janssen-Cilag KFT Beograd |
| Imbruvica Capsules 140mg | Taiwan | 膠囊劑 | Authorised | 嬌生股份有限公司 |